Small ubiquitin-related modifier (SUMO) pathwaymediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO- 1/3 proteins to viral replication compartments

Journal of General Virology

Volumn 94, Issue PART 6, 2013, Pages 1373-1384

  Scherer, Myriam ^a   Reuter, Nina ^a   Wagenknecht, Nadine ^a   Otto, Victoria ^a   Sticht, Heinrich ^a   Stamminger, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; VIRUS DNA;

ANTIVIRAL RESISTANCE; ARTICLE; CELL NUCLEUS INCLUSION BODY; CONJUGATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUMOYLATION; VIRUS PARTICLE; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84877940759     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.051078-0     Document Type: Article

References (35)

1. Ahn, J. H. & Hayward, G. S. (1997). The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71, 4599-4613.
2. Andreoni, M., Faircloth, M., Vugler, L. & Britt, W. J. (1989). A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods 23, 157-167.
3. Berndt, A., Hofmann-Winkler, H., Tavalai, N., Hahn, G. & Stamminger, T. (2009). Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection. J Virol 83, 12881-12894.
4. Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. & Freemont, P. S. (1996). PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971-982.
5. Boggio, R. & Chiocca, S. (2006). Viruses and sumoylation: recent highlights. Curr Opin Microbiol 9, 430-436.
6. Boutell, C., Cuchet-Lourenço, D., Vanni, E., Orr, A., Glass, M., McFarlane, S. & Everett, R. D. (2011). A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog 7, e1002245.
7. Da Silva-Ferrada, E., Lopitz-Otsoa, F., Lang, V., Rodríguez, M. S. & Matthiesen, R. (2012). Strategies to identify recognition signals and targets of SUMOylation. Biochem Res Int 2012, 875148.
8. Dinkel, H., Michael, S., Weatheritt, R. J., Davey, N. E., van Roey, K., Altenberg, G., Toedt, G., Uyar, B., Seiler, M., Budd, A., Jödicke, L., Dammert, M. A., Schroeter, C., Hammer, M., Schmidt, T., Jehl, P., McGuigan, C., Dymecka, M., Chica, C., Luck, Y., Via, A., Chatr-Aryamontri, A., Haslam, N., Grebnev, G., Edwards, R. J., Steinmetz, M. O., Meiselbach, H., Diella, F. & Gibson, J. F. (2012). ELM-the database of eukaryotic linear motifs. Nucl. Acids Res 40, D242-51.
9. Elliott, G. & O'Hare, P. (1999). Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J Virol 73, 4110-4119.
10. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. & Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasomedependent loss of several PML isoforms. J Virol 72, 6581-6591.
11. Hahn, G., Khan, H., Baldanti, F., Koszinowski, U. H., Revello, M. G. & Gerna, G. (2002). The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol 76, 9551-9555.
12. Hofmann, H., Flöss, S. & Stamminger, T. (2000). Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 74, 2510-2524.
13. Huh, Y. H., Kim, Y. E., Kim, E. T., Park, J. J., Song, M. J., Zhu, H., Hayward, G. S. & Ahn, J. H. (2008). Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol 82, 10444-10454.
14. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., III & Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234.
15. Johnson, E. S. (2004). Protein modification by SUMO. Annu Rev Biochem 73, 355-382.
16. Kim, Y. E., Lee, J. H., Kim, E. T., Shin, H. J., Gu, S. Y., Seol, H. S., Ling, P. D., Lee, C. H. & Ahn, J. H. (2011). Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol 85, 11928-11937.
17. Korioth, F., Maul, G. G., Plachter, B., Stamminger, T. & Frey, J. (1996). The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229, 155-158.
18. Lee, H. R. & Ahn, J. H. (2004). Sumoylation of the major immediateearly IE2 protein of human cytomegalovirus Towne strain is not required for virus growth in cultured human fibroblasts. J Gen Virol 85, 2149-2154.
19. Lee, H. R., Kim, D. J., Lee, J. M., Choi, C. Y., Ahn, B. Y., Hayward, G. S. & Ahn, J. H. (2004). Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78, 6527-6542.
20. Lorz, K., Hofmann, H., Berndt, A., Tavalai, N., Mueller, R., Schlötzer-Schrehardt, U. & Stamminger, T. (2006). Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol 80, 5423-5434.
21. Marschall, M., Freitag, M., Weiler, S., Sorg, G. & Stamminger, T. (2000). Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44, 1588-1597.
22. Müller, S. & Dejean, A. (1999). Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 73, 5137-5143.
23. Müller, S., Hoege, C., Pyrowolakis, G. & Jentsch, S. (2001). SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2, 202-210.
24. Nevels, M., Brune, W. & Shenk, T. (2004). SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78, 7803-7812.
25. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. & Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol Cell 24, 331-339.
26. Sinigalia, E., Alvisi, G., Segré, C. V., Mercorelli, B., Muratore, G., Winkler, M., Hsiao, H. H., Urlaub, H., Ripalti, A. & other authors (2012). The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner. PLoS ONE 7, e49630.
27. Sinzger, C., Hahn, G., Digel, M., Katona, R., Sampaio, K. L., Messerle, M., Hengel, H., Koszinowski, U., Brune, W. & Adler, B. (2008). Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89, 359-368.
28. Sourvinos, G., Tavalai, N., Berndt, A., Spandidos, D. A. & Stamminger, T. (2007). Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol 81, 10123-10136.
29. Tavalai, N. & Stamminger, T. (2009). Interplay between herpesvirus infection and host defense by PML nuclear bodies. Viruses 1, 1240-1264.
30. Tavalai, N., Papior, P., Rechter, S., Leis, M. & Stamminger, T. (2006). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80, 8006-8018.
31. Tavalai, N., Adler, M., Scherer, M., Riedl, Y. & Stamminger, T. (2011). Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol 85, 9447-9458.
32. Van Damme, E., Laukens, K., Dang, T. H. & Van Ostade, X. (2010). A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci 6, 51-67.
33. Wilkinson, K. A. & Henley, J. M. (2010). Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 428, 133-145.
34. Wimmer, P., Schreiner, S. & Dobner, T. (2012). Human pathogens and the host cell SUMOylation system. J Virol 86, 642-654.
35. Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A. & Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.